bufexamac has been researched along with Dermatitis, Atopic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gefeller, O; Schnuch, A; Uter, W | 1 |
| Bayou, F; Belhadjali, H; Chakroun, M; Ghannouchi, N; Mohamed, M; Moussa, A; Njim, L; Zakhama, A; Zili, J | 1 |
| Perras, M; Proulx, C; Ricard, P | 1 |
| Kimata, H | 2 |
| Christiansen, JV; Gadborg, E; Kleiter, I; Ludvigsen, K; Meier, CH; Norholm, A; Raaschou-Nielsen, W; Reiter, H; Reymann, F; Sondergaard, M; Unna, P; Wehnert, R | 1 |
3 trial(s) available for bufexamac and Dermatitis, Atopic
| Article | Year |
|---|---|
Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Arylsulfonates; Bufexamac; Dermatitis, Atopic; Dexamethasone; Female; Histamine Antagonists; Humans; Immunoglobulin E; Immunoglobulin G; Interleukins; Lymphokines; Male; Substance Withdrawal Syndrome; Sulfonium Compounds; Th2 Cells; Treatment Outcome | 1999 |
Effect of nadifloxacin on atopic dermatitis with methicillin-resistant Staphylococcus aureus in young children.
Topics: Administration, Topical; Anti-Infective Agents; Anti-Inflammatory Agents; Bufexamac; Dermatitis, Atopic; Female; Fluoroquinolones; Follow-Up Studies; Humans; Infant; Male; Methicillin Resistance; Quinolizines; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 1999 |
Efficacy of bufexamac (NFN) cream in skin diseases. A double-blind multicentre trial.
Topics: Administration, Topical; Anti-Inflammatory Agents; Bufexamac; Clinical Trials as Topic; Dermatitis, Atopic; Dermatitis, Contact; Dermatitis, Seborrheic; Drug Evaluation; Humans; Hydrocortisone; Hydroxamic Acids; Placebos; Skin Diseases; Triamcinolone Acetonide | 1977 |
3 other study(ies) available for bufexamac and Dermatitis, Atopic
| Article | Year |
|---|---|
[A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Bufexamac; Cross-Sectional Studies; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dermatology; Drug Eruptions; Female; Germany; Hospital Departments; Humans; Information Services; Male; Middle Aged; Patch Tests; Poisson Distribution; Risk Factors; Statistics as Topic; Topography, Medical | 2005 |
Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Bufexamac; Child, Preschool; Dermatitis, Allergic Contact; Dermatitis, Atopic; Drug Eruptions; Exanthema; Female; Humans; Patch Tests | 2008 |
[A preliminary study of bufexamac in pediatric dermatology].
Topics: Adolescent; Bufexamac; Child; Child, Preschool; Dermatitis, Atopic; Female; Humans; Hydroxamic Acids; Infant; Male | 1980 |